Privia Health Group, Inc. Proceeds from Stock Options Exercised
Privia Health Group, Inc. (PRVA) reported Proceeds from Stock Options Exercised of $1.60 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2026-08-06
- Privia Health Group, Inc. proceeds from stock options exercised for the quarter ending 2026-06-30 was $826.00K, a 56.13% decline year-over-year.
- Privia Health Group, Inc. proceeds from stock options exercised for the quarter ending 2026-03-31 was $774.00K, a 65.49% decline year-over-year.
- Privia Health Group, Inc. proceeds from stock options exercised for the quarter ending 2025-12-31 was $3.49M, a 463.81% increase year-over-year.
- Privia Health Group, Inc. proceeds from stock options exercised for the quarter ending 2025-09-30 was $431.00K, a 48.57% decline year-over-year.
- Privia Health Group, Inc. proceeds from stock options exercised for fiscal 2025 was $8.05M, a 200.15% increase from fiscal 2024.
- Privia Health Group, Inc. proceeds from stock options exercised for fiscal 2024 was $2.68M, a 69.32% decline from fiscal 2023.
- Privia Health Group, Inc. proceeds from stock options exercised for fiscal 2023 was $8.74M, a 35.01% decline from fiscal 2022.
- Privia Health Group, Inc. proceeds from stock options exercised for fiscal 2022 was $13.45M, a 251.21% increase from fiscal 2021.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2026-06-30 | $826.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.60M 10-Q · filed 2026-08-06 | $5.09M derived: sum of 3 quarters · filed 2026-08-06 | $5.52M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $774.00K 10-Q · filed 2026-05-07 | $4.26M derived: sum of 2 quarters · filed 2026-05-07 | $4.70M derived: sum of 3 quarters · filed 2026-05-07 | $6.58M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $3.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $3.92M derived: sum of 2 quarters · filed 2026-02-27 | $5.80M derived: sum of 3 quarters · filed 2026-08-06 | $8.05M 10-K · filed 2026-02-27 |
| 2025-09-30 | $431.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.31M derived: sum of 2 quarters · filed 2026-08-06 | $4.56M 10-Q · filed 2025-11-06 | $5.18M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.13M 10-Q · filed 2026-08-06 | $4.75M derived: sum of 3 quarters · filed 2026-08-06 | $5.58M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $2.24M 10-Q · filed 2026-05-07 | $2.86M derived: sum of 2 quarters · filed 2026-05-07 | $3.70M derived: sum of 3 quarters · filed 2026-05-07 | $4.45M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $619.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.46M derived: sum of 2 quarters · filed 2026-02-27 | $2.21M derived: sum of 3 quarters · filed 2026-02-27 | $2.68M 10-K · filed 2026-02-27 |
| 2024-09-30 | $838.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.59M derived: sum of 2 quarters · filed 2025-11-06 | $2.06M 10-Q · filed 2025-11-06 | $2.01M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $749.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.22M 10-Q · filed 2025-08-07 | $1.18M derived: sum of 3 quarters · filed 2026-02-27 | $4.18M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $475.00K 10-Q · filed 2025-05-08 | $427.00K derived: sum of 2 quarters · filed 2026-02-27 | $3.43M derived: sum of 3 quarters · filed 2026-02-27 | $7.74M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | -$48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $2.96M derived: sum of 2 quarters · filed 2026-02-27 | $7.26M derived: sum of 3 quarters · filed 2026-02-27 | $8.74M 10-K · filed 2026-02-27 |
| 2023-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $7.31M derived: sum of 2 quarters · filed 2024-11-07 | $8.79M 10-Q · filed 2024-11-07 | $10.74M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $4.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $5.78M 10-Q · filed 2024-08-08 | $7.74M derived: sum of 3 quarters · filed 2025-02-27 | $16.31M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $1.48M 10-Q · filed 2024-05-09 | $3.43M derived: sum of 2 quarters · filed 2025-02-27 | $12.01M derived: sum of 3 quarters · filed 2025-02-27 | $14.13M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $10.53M derived: sum of 2 quarters · filed 2025-02-27 | $12.65M derived: sum of 3 quarters · filed 2025-02-27 | $13.45M 10-K · filed 2025-02-27 |
| 2022-09-30 | $8.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $10.69M derived: sum of 2 quarters · filed 2023-11-03 | $11.49M 10-Q · filed 2023-11-03 | $14.67M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $2.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $2.92M 10-Q · filed 2023-08-03 | $6.10M derived: sum of 3 quarters · filed 2024-02-27 | $6.75M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $799.00K 10-Q · filed 2023-05-04 | $3.98M derived: sum of 2 quarters · filed 2024-02-27 | $4.63M derived: sum of 3 quarters · filed 2024-02-27 | $4.63M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $3.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $3.83M derived: sum of 2 quarters · filed 2024-02-27 | $3.83M derived: sum of 3 quarters · filed 2024-02-27 | $3.83M 10-K · filed 2024-02-27 |
| 2021-09-30 | $648.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $648.00K derived: sum of 2 quarters · filed 2022-11-10 | $648.00K 10-Q · filed 2022-11-10 | $648.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | $0.00 derived: sum of 3 quarters · filed 2023-03-01 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $108.00K 10-K · filed 2023-03-01 | ||
| 2020-09-30 | $108.00K 10-Q · filed 2021-11-08 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |